The interaction of direct-to-consumer prescription drug advertising and stakeholders in the medication use process

Research in Social and Administrative Pharmacy

Volumn 1, Issue 2, 2005, Pages 135-138

  Desselle, Shane P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERTIZING; DRUG INDUSTRY; DRUG UTILIZATION; EDITORIAL;

ADVERTISING; ADVERTISING AS TOPIC; DRUG INDUSTRY; DRUG UTILIZATION; PHARMACEUTICAL PREPARATIONS;

EID: 33745953729     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2005.03.001     Document Type: Editorial

References (20)

1. Rosenthal M.B., Berndt E.R., Donohue J.M., Frank R.G., and Epstein A.M. Promotion of prescription drugs to consumers. N Engl J Med 346 (2002) 498-505
2. Kemper D.W., and Mettler M. A consumer-empowered response to direct-to-consumer advertising of prescription drugs. Manag Care Q 10 (2002) 52-54
3. Bradley L.R., and Zito J.M. Direct-to-consumer prescription drug advertising. Med Care 35 (1997) 86-92
4. Lipsky M.S., and Taylor C.A. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract 45 (1997) 495-499
5. Levy S. What do consumers really think about DTC Rx Ads? Available at http://www.DrugTopics.com. Accessed on March 19, 1999.
6. Pinto M.B. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychol Rep 86 (2000) 597-607
7. Woloshin S., Schwartz L.M., Tremmel J., and Welch H.G. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?. Lancet 358 (2000) 1141-1146
8. Holmes E.R., and Desselle S.P. Evaluating the balance of informative and persuasive content within product-specific print DTCs ads. Drug Inf J 38 (2004) 83-98
9. Zachry W.M., Shepherd M.D., Hinich M.J., et al. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm 59 (2002) 42-49
10. Glinert L.H. TV commercials for prescription drugs: a discourse analytic perspective. Res Soc Adm Pharm 1 (2005) 158-184
11. Glinert L.H., and Schommer J.C. Television advertisement format and the provision of risk information about prescription drug products. Res Soc Adm Pharm 1 (2005) 185-210
12. Sewak S., Wilkin N., Bentley J., and Smith M. Direct-to-consumer advertising via the Internet: the role of Web site design. Res Soc Adm Pharm 1 (2005) 289-309
13. Liu Y., Doucette W.R., Farris K.B., and Nayakankuppam D. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisements of prescription drugs. Res Soc Adm Pharm 1 (2005) 251-269
14. Young H.N., Lipwoski E.E., and Cline R.J.W. Using social cognitive theory to explain consumers' behavioral intentions in response to direct-to-consumer prescription drug advertising. Res Soc Adm Pharm 1 (2005) 270-288
15. Hansen R.A., Schommer J.C., Cline R.R., Hadsall R.S., Schondelmeyer S.W., and Nyman J.A. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Res Soc Adm Pharm 1 (2005) 139-157
16. Schommer J.C., Singh R.L., and Hansen R.A. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Res Soc Adm Pharm 1 (2005) 231-250
17. Shah M.B., Bentley J.P., McCaffrey D.J., and Kolassa E.M. Direct-to-consumer advertisements and the patient-physician relationship. Res Soc Adm Pharm 1 (2005) 211-230
18. Hansen R.A., and Droedge M. Methodological challenges surrounding direct-to-consumer advertising research: the measurement conundrum. Res Soc Adm Pharm 1 (2005) 331-347
19. Schommer J.C., and Hansen R.A. The study of direct-to-consumer advertising of prescription drugs. Res Soc Adm Pharm 1 (2005) 348-368
20. Mintzes B., Barer M., Lexchin J., and Bassett K.L. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Res Soc Adm Pharm 1 (2005) 310-330